CCL22 and neoplasm: CCL22 recruits Treg cells in the tumor microenvironment (TME) and treg cells could competitively bind with cytotoxic lymphocyte (CTL), thereby inhibiting the proliferation of CTL and contributing to immune suppression [23, 24].